Component
Allicin-evoked current through rat TRPV1 in HEK293 patches
Allicin-evoked current through rat TRPV1 in HEK293 patches. Interpret through the linked study species, preparation, exposure and measured endpoint.
5 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
A reducing agent reversed allicin-evoked TRPV1 activation in the patch assay.
Experimental context and source evidence
- evidence_access
- Primary full text available; selected claim-relevant methods, results, tables/figures and limitations reviewed. Supplemental proteome and all secondary findings are not exhaustively extracted.
- experimental_condition
- Allicin-activated channel before DTT prior exposure · Allicin Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- Allicin-activated channel before DTT added · Dithiothreitol / DTT Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "DTT after allicin", "comparator": "Allicin-activated channel before DTT", "endpoint": "A reducing agent reversed allicin-evoked TRPV1 activation in the patch assay.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "dithiothreitol", "state": "added"}, {"entity_slug": "allicin", "state": "prior exposure"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Rat TRPV1 in HEK293; DTT addition after allicin exposure.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Experimental reducing agent, not an oral treatment recommendation.
- plain_language
- A reducing agent reversed allicin-evoked TRPV1 activation in the patch assay.
- primary_references
- A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic. | 2008 | DOI 10.1038/nn2056 | PMID 18297068 | https://pubmed.ncbi.nlm.nih.gov/18297068/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC4370189/ | https://doi.org/10.1038/nn2056
- source_locator
- Reviewed reference lines 73-73; exact primary location described in quoted passage where extracted.
Allicin: detailed mechanisms of action (reviewed 5 October 2026) · lines 73–73
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat TRPV1 in HEK293; DTT addition after allicin exposure. · source_derived_draft · unverified_draft
**A tested TRPV1 cysteine.** In rat TRPV1 expressed in HEK293 cells, the C157A substitution eliminated allicin responsiveness; reinserting C157 into a cysteine-less construct restored it. Capsaicin responsiveness persisted in the relevant mutant controls. A reducing agent reversed activation. This is direct functional evidence for a cysteine-dependent activation mechanism in that construct, not proof that every electrophile makes the same adduct or that the cell line makes the protein human. [Salazar 2008](https://pmc.ncbi.nlm.nih.gov/articles/PMC4370189/)
Complete structured claim and evidenceAllicin activated rat TRPV1 expressed in HEK293 membrane patches.
Experimental context and source evidence
- evidence_access
- Primary full text available; selected claim-relevant methods, results, tables/figures and limitations reviewed. Supplemental proteome and all secondary findings are not exhaustively extracted.
- experimental_contrast
- {"intervention": "Allicin exposure", "comparator": "Patch before allicin", "endpoint": "Allicin activated rat TRPV1 expressed in HEK293 membrane patches.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Rat TRPV1 construct in human HEK293 host cells; inside-out patch recordings.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
- plain_language
- Allicin activated rat TRPV1 expressed in HEK293 membrane patches.
- primary_references
- A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic. | 2008 | DOI 10.1038/nn2056 | PMID 18297068 | https://pubmed.ncbi.nlm.nih.gov/18297068/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC4370189/ | https://doi.org/10.1038/nn2056
- source_locator
- Reviewed reference lines 73-73; exact primary location described in quoted passage where extracted.
Allicin: detailed mechanisms of action (reviewed 5 October 2026) · lines 73–73
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat TRPV1 construct in human HEK293 host cells; inside-out patch recordings. · source_derived_draft · unverified_draft
**A tested TRPV1 cysteine.** In rat TRPV1 expressed in HEK293 cells, the C157A substitution eliminated allicin responsiveness; reinserting C157 into a cysteine-less construct restored it. Capsaicin responsiveness persisted in the relevant mutant controls. A reducing agent reversed activation. This is direct functional evidence for a cysteine-dependent activation mechanism in that construct, not proof that every electrophile makes the same adduct or that the cell line makes the protein human. [Salazar 2008](https://pmc.ncbi.nlm.nih.gov/articles/PMC4370189/)
Complete structured claim and evidenceRestoring C157 to the cysteine-less rat TRPV1 construct restored responsiveness to allicin.
Experimental context and source evidence
- evidence_access
- Primary full text available; selected claim-relevant methods, results, tables/figures and limitations reviewed. Supplemental proteome and all secondary findings are not exhaustively extracted.
- experimental_condition
- Cysteine-less construct at corresponding allicin exposure applied · Allicin Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- Cysteine-less construct at corresponding allicin exposure expressed · Rat TRPV1 cysteine-less construct with C157 restored Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "Allicin applied to C157-restored construct", "comparator": "Cysteine-less construct at corresponding allicin exposure", "endpoint": "Restoring C157 to the cysteine-less rat TRPV1 construct restored responsiveness to allicin.", "effect_direction": "increase", "combination": "joint", "conditions": [{"entity_slug": "rat-trpv1-c157-only", "state": "expressed"}, {"entity_slug": "allicin", "state": "applied"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Rat TRPV1 C157-only construct in HEK293; Figure 8.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
- plain_language
- Restoring C157 to the cysteine-less rat TRPV1 construct restored responsiveness to allicin.
- primary_references
- A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic. | 2008 | DOI 10.1038/nn2056 | PMID 18297068 | https://pubmed.ncbi.nlm.nih.gov/18297068/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC4370189/ | https://doi.org/10.1038/nn2056
- source_locator
- Reviewed reference lines 73-73; exact primary location described in quoted passage where extracted.
Allicin: detailed mechanisms of action (reviewed 5 October 2026) · lines 73–73
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat TRPV1 C157-only construct in HEK293; Figure 8. · source_derived_draft · unverified_draft
**A tested TRPV1 cysteine.** In rat TRPV1 expressed in HEK293 cells, the C157A substitution eliminated allicin responsiveness; reinserting C157 into a cysteine-less construct restored it. Capsaicin responsiveness persisted in the relevant mutant controls. A reducing agent reversed activation. This is direct functional evidence for a cysteine-dependent activation mechanism in that construct, not proof that every electrophile makes the same adduct or that the cell line makes the protein human. [Salazar 2008](https://pmc.ncbi.nlm.nih.gov/articles/PMC4370189/)
Complete structured claim and evidenceThe rat-trpv1-c157a construct did not show allicin responsiveness while relevant capsaicin responses persisted.
Experimental context and source evidence
- evidence_access
- Primary full text available; selected claim-relevant methods, results, tables/figures and limitations reviewed. Supplemental proteome and all secondary findings are not exhaustively extracted.
- experimental_condition
- Same mutant patch before allicin expressed · Rat TRPV1 C157A experimental construct Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- Same mutant patch before allicin applied · Allicin Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "Allicin applied to rat-trpv1-c157a", "comparator": "Same mutant patch before allicin", "endpoint": "The rat-trpv1-c157a construct did not show allicin responsiveness while relevant capsaicin responses persisted.", "effect_direction": "no_detected_change", "combination": "joint", "conditions": [{"entity_slug": "rat-trpv1-c157a", "state": "expressed"}, {"entity_slug": "allicin", "state": "applied"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Rat channel variant expressed in HEK293; Figure 8 functional comparison.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- No response to allicin, not nonfunctional protein. Human homolog residue numbers are not silently assigned.
- plain_language
- The rat-trpv1-c157a construct did not show allicin responsiveness while relevant capsaicin responses persisted.
- primary_references
- A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic. | 2008 | DOI 10.1038/nn2056 | PMID 18297068 | https://pubmed.ncbi.nlm.nih.gov/18297068/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC4370189/ | https://doi.org/10.1038/nn2056
- source_locator
- Reviewed reference lines 73-73; exact primary location described in quoted passage where extracted.
Allicin: detailed mechanisms of action (reviewed 5 October 2026) · lines 73–73
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat channel variant expressed in HEK293; Figure 8 functional comparison. · source_derived_draft · unverified_draft
**A tested TRPV1 cysteine.** In rat TRPV1 expressed in HEK293 cells, the C157A substitution eliminated allicin responsiveness; reinserting C157 into a cysteine-less construct restored it. Capsaicin responsiveness persisted in the relevant mutant controls. A reducing agent reversed activation. This is direct functional evidence for a cysteine-dependent activation mechanism in that construct, not proof that every electrophile makes the same adduct or that the cell line makes the protein human. [Salazar 2008](https://pmc.ncbi.nlm.nih.gov/articles/PMC4370189/)
Complete structured claim and evidenceThe rat-trpv1-cysteine-less construct did not show allicin responsiveness while relevant capsaicin responses persisted.
Experimental context and source evidence
- evidence_access
- Primary full text available; selected claim-relevant methods, results, tables/figures and limitations reviewed. Supplemental proteome and all secondary findings are not exhaustively extracted.
- experimental_condition
- Same mutant patch before allicin applied · Allicin Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- Same mutant patch before allicin expressed · Rat TRPV1 cysteine-less experimental construct Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "Allicin applied to rat-trpv1-cysteine-less", "comparator": "Same mutant patch before allicin", "endpoint": "The rat-trpv1-cysteine-less construct did not show allicin responsiveness while relevant capsaicin responses persisted.", "effect_direction": "no_detected_change", "combination": "joint", "conditions": [{"entity_slug": "rat-trpv1-cysteine-less", "state": "expressed"}, {"entity_slug": "allicin", "state": "applied"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Rat channel variant expressed in HEK293; Figure 8 functional comparison.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- No response to allicin, not nonfunctional protein. Human homolog residue numbers are not silently assigned.
- plain_language
- The rat-trpv1-cysteine-less construct did not show allicin responsiveness while relevant capsaicin responses persisted.
- primary_references
- A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic. | 2008 | DOI 10.1038/nn2056 | PMID 18297068 | https://pubmed.ncbi.nlm.nih.gov/18297068/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC4370189/ | https://doi.org/10.1038/nn2056
- source_locator
- Reviewed reference lines 73-73; exact primary location described in quoted passage where extracted.
Allicin: detailed mechanisms of action (reviewed 5 October 2026) · lines 73–73
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat channel variant expressed in HEK293; Figure 8 functional comparison. · source_derived_draft · unverified_draft
**A tested TRPV1 cysteine.** In rat TRPV1 expressed in HEK293 cells, the C157A substitution eliminated allicin responsiveness; reinserting C157 into a cysteine-less construct restored it. Capsaicin responsiveness persisted in the relevant mutant controls. A reducing agent reversed activation. This is direct functional evidence for a cysteine-dependent activation mechanism in that construct, not proof that every electrophile makes the same adduct or that the cell line makes the protein human. [Salazar 2008](https://pmc.ncbi.nlm.nih.gov/articles/PMC4370189/)
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.